Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-12-10 1:18 pm Sale |
2021-11-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
1,775,704 3.530% |
-841,896 (-32.16%) |
Filing History |
| 2021-03-08 11:04 am Purchase |
2009-02-28 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
PRIMECAP MANAGEMENT CO | 5,570,691 11.140% |
1,228,200 (+28.28%) |
Filing History |
| 2021-02-16 5:04 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
Baker Bros. Advisors LP | 2,314,873 5.200% |
-393,327 (-14.52%) |
Filing History |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 4,179,067 9.500% |
-1,243,245 (-22.93%) |
Filing History |
| 2021-02-12 3:20 pm Purchase |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
2,617,600 5.920% |
2,617,600 (New Position) |
Filing History |
| 2021-02-12 12:31 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
Flynn James E | 2,721,203 6.160% |
-1,568,088 (-36.56%) |
Filing History |
| 2021-02-12 12:02 pm Purchase |
2009-02-28 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
PRIMECAP MANAGEMENT CO | 4,342,491 9.820% |
799,900 (+22.58%) |
Filing History |
| 2021-02-11 5:11 pm Purchase |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
JANUS HENDERSON GROUP PLC JHG |
4,491,765 10.200% |
76,296 (+1.73%) |
Filing History |
| 2021-02-04 10:14 am Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
WELLINGTON MANAGEMENT CO LLP | 2,101,227 4.750% |
-1,219,524 (-36.72%) |
Filing History |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BLACKROCK INC BLK |
2,731,106 6.200% |
176,340 (+6.90%) |
Filing History |
| 2020-06-26 3:27 pm Sale |
2020-06-24 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
MPM BIOVENTURES V L.P. | 1,934,558 4.400% |
-468,939 (-19.51%) |
Filing History |
| 2020-05-11 11:58 am Purchase |
2020-04-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
JANUS HENDERSON GROUP PLC JHG |
4,415,469 10.000% |
110,221 (+2.56%) |
Filing History |
| 2020-04-24 3:39 pm Purchase |
2009-02-28 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
PRIMECAP MANAGEMENT CO | 3,542,591 8.040% |
3,542,591 (New Position) |
Filing History |